Status:
COMPLETED
Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Covid-19
Eligibility:
FEMALE
18-43 years
Brief Summary
Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a ...
Eligibility Criteria
Inclusion
- Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age
- Patient who has already signed a consent to management
Exclusion
- Patient who expressed opposition to participating in the study
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04415359
Start Date
August 1 2020
End Date
December 31 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Clinico biologique d'Assistance Médicale à La Procréation
Strasbourg, France, 67091